Selling a Veterinary Practice to an Associate: The 2026 Buy-In Guide

Key takeaways

• Selling a veterinary practice to an associate is the internal path — a phased buy-in where the doctor who already works for you becomes the doctor who owns it, usually over years rather than in one closing.
• The associate almost always pays less than a competitive external sale would produce. Doctor-to-doctor deals have historically priced near 80 percent of annual revenue, while well-capitalized outside buyers can pay well above that — so the internal route trades price for legacy and a gentler transition.
• Financing is the hard part, not the handshake. Banks resist partial buy-ins, so seller financing or an SBA loan usually carries the deal — and the June 2025 SBA rules changed what each side has to guarantee.
• It runs on three agreements, not one. A purchase agreement, a partnership or operating agreement, and an updated employment agreement all have to fit together, ideally drafted by a veterinary deal attorney.
• Most internal deals that fail, fail on process — skipped diligence, a vague contract, unqualified financing — not on bad feelings between two doctors who like each other.

A vet I talked with last year had it all figured out before he ever called me. His associate had been with the practice for 8 years.

She was beloved by clients, ran her own book, and had said more than once that she wanted to own the place someday. So he was going to sell it to her.

Clean, simple, no strangers walking through the door.

Then he asked me one question over the phone that stopped him cold. “What’s it actually worth, and can she even pay for it?” He had never put a real number on the practice, and he had no idea how a single associate finances a seven-figure purchase. He liked the idea of the internal sale.

He had not priced the idea.

That gap is what this article is about. Selling a veterinary practice to an associate is one of the most natural-feeling exits there is, and it is genuinely the most common path for a lot of multi-doctor practices. It is also the one owners romanticize most and plan for least.

If you are weighing an internal, vet-to-vet sale, here is the honest version of how it works, what it costs you in price, and what makes the difference between a smooth handoff and a deal that quietly falls apart.

Selling a veterinary practice to an associate means an internal sale where an employed doctor buys the practice, usually in phases rather than all at once. A common structure has the associate pay an initial 10 to 20 percent up front, then buy the rest over time under a promissory note, with the whole thing built on three agreements: a purchase agreement, a partnership or operating agreement, and an updated employment agreement.

The internal price is typically lower than a competitive external sale, and the trade you are making is price for legacy, control of the timeline, and a mentored transition.

What an associate buy-in actually is

Let me define the thing plainly, because “buy-in” gets used loosely.

An associate buy-in is a phased internal sale — an employed associate veterinarian buys a percentage of the practice over a set period, often something like 10 percent per year over five years, until they become a partner or buy out your remaining interest. The veterinary law firm Mandelbaum Barrett describes exactly this structure as the standard form: an associate steadily acquires ownership until they either sit beside you as a partner or take the whole thing.

The percentages and the timeline are negotiable, and they vary deal to deal. What stays consistent is the shape.

The associate does not write one big check on one closing day. They become an owner in stages, and you usually stay involved while they do.

There is a money mechanic underneath it. In a typical buy-in the associate pays an initial 10 to 20 percent up front, and the rest gets paid over time under a promissory note — a written promise to repay a set amount on a set schedule, with interest.

Mandelbaum Barrett frames that 10-to-20-percent initial slice as the usual range, not a fixed rule.

And there is one more lever that makes internal deals different from any external sale. Sweat equity — ownership the associate earns through contributed work over time rather than cash — can count toward their buy-in percentage. An associate who keeps building the practice can earn part of their stake by the value they create, which is something no outside buyer ever brings to the table.

How the internal path compares to selling outside

Here is the part owners least want to hear and most need to.

When you sell to your associate, you are selling to one buyer with one checkbook. When you run a competitive external process, you are selling into a market of well-capitalized buyers who compete for your practice.

Those are not the same economics, and the price reflects it.

We often describe the associate buy-in as an unfair fight on price, and the math behind that is worth seeing laid out. Doctor-to-doctor sales have historically priced around 80 percent of annual revenue.

PE-backed consolidators, the private equity-backed groups that acquire practices and operate them at scale, pay well above 100 percent of annual revenue, buying at roughly 10 times EBITDA — what your practice earns in pure operating profit, before taxes and accounting choices — and can pay meaningfully more for a given clinic than a doctor buyer could.

The table below is the comparison I draw for every owner who tells me they have already decided to sell internally. I am not drawing it to talk them out of it.

I am drawing it so they know what they are choosing.

Dimension	Internal sale to an associate	Competitive external sale
Pool of buyers	One associate, one checkbook	A vetted field of qualified, competing buyers
Typical pricing reference	Historically near 80 percent of annual revenue (vet-to-vet)	Well above 100 percent of revenue; roughly 10x EBITDA for PE-backed buyers
Financing	Often seller-financed; banks resist partial buy-ins	Buyer is already capitalized
Transition	Gradual, mentored, on your timeline	Defined post-close employment, buyer-set integration
Legacy and culture	Highest protection — your name carries on	Varies by buyer; PE-backed groups generally keep local branding
Restrictive covenants	Typically lighter non-compete and non-solicitation terms	Buyer-set, often firmer
Speed and certainty	Slower to plan; financing is the bottleneck	Faster once a process is run; competition creates certainty

Why does the gap exist? Size and competition.

Industry valuation data puts general-practice clinics with $1M to $5M of EBITDA in the range of 8 to 9 times EBITDA, rising toward the low double digits at $5M to $10M of EBITDA, while the smallest clinics at $500K to $1M of EBITDA sit nearer 5 times. Revenue multiples follow the same shape — roughly 1.5 to 1.7 times for $1M to $3M-revenue practices and a bit above 2 times for $3M to $10M-revenue practices.

Read those bands again. The multiple climbs with size and with the number of buyers fighting over the asset, and a single associate cannot manufacture either one.

That is the whole reason the internal price runs lower.

None of this makes the external buyers the villains, and none of it makes the associate path wrong. PE-backed groups, family-owned strategics like Mars Veterinary Health, and individual buyers all pay what the competition and the profile justify.

The associate simply starts from a different place. If you want to see what the outside market would actually pay before you commit, that is exactly what a free practice value estimate is for, and it costs you nothing to know.

What you trade the price for

So if the associate pays less, why does anyone sell internally? Because price is not the only thing on the table, and for a lot of owners it is not even the most important thing.

The internal sale buys you legacy. Your name, your culture, your standard of care, carried forward by someone you trained rather than reset by someone you have never met.

In our experience the internal sale is often the most common exit for multi-doctor practices precisely because it protects the things owners built the practice around.

It also buys you a gradual, mentored transition. You are not handing over the keys and walking out.

You phase down while your associate phases up, and clients feel continuity instead of rupture.

And the terms tend to be gentler in one specific way. Internal sales typically come with less restrictive non-compete and non-solicitation terms — the clauses that limit where and how a seller can practice afterward — than the firmer covenants an outside buyer usually requires.

For an owner who still wants to see patients a few days a week somewhere, that flexibility is worth real money.

The honest framing is a trade, not a free lunch. You accept a lower headline number in exchange for control of the timeline, protection of your life’s work, and a softer landing.

Plenty of owners make that trade happily. The mistake is making it without knowing the size of the price gap you are accepting, which is why I push every owner to get a real external read first.

You can always choose legacy over dollars. You should not do it blind.

Financing the associate: the part that actually decides the deal

Here is where most internal deals live or die, and it has nothing to do with whether the two doctors get along.

Your associate is a veterinarian, not a private equity fund. They probably do not have a seven-figure check sitting in an account.

So the question is not really “will she buy it.” The question is “how does she pay for it,” and the answer is messier than owners expect.

Start with the bank, because most owners assume the bank solves this. It often does not.

In practice, banks are frequently reluctant to finance an associate buy-in because they want a first-lien position on the entire practice — the first claim on the practice’s assets if the loan goes bad — and a selling owner who keeps majority ownership during a phased buy-in usually cannot grant that. The bank wants security you are not in a position to give.

That is why seller financing so often becomes the practical solution — you, rather than a bank, lend the associate the money to buy in, and they repay you over time under a promissory note, usually out of the profits their new ownership stake generates. The associate’s own slice of the practice becomes the engine that pays you back.

It works, but it means your exit is not fully cashed out on closing day. You are carrying paper.

The SBA route, and what changed in June 2025

The other common path is an SBA loan, a small-business loan partially guaranteed by the U.S. Small Business Administration, which is often used to finance practice acquisitions.

Lenders publish ranges showing single-doctor practice acquisitions typically running $500,000 to $1.5M and multi-doctor hospitals $2M to $5M, with most conventional lenders wanting 10 to 20 percent down while SBA loans can require as little as 0 to 10 percent. That lower down-payment is why associates reach for the SBA.

But the rules tightened, and the details matter. Under the SBA’s SOP 50 10 8, effective June 1, 2025, a business-acquisition buyer must provide a 10 percent equity injection and contribute at least half of it, typically around 5 percent of the purchase price, in cash.

A seller note can count toward the other half only if it is on full standby — meaning no principal or interest payments at all — for the entire loan term.

The bigger change is aimed straight at phased buy-ins. Under the June 2025 update, in a partial buy-in where the seller retains any ownership, all equity holders, including the retained seller, must personally guarantee the entire SBA loan for at least two years.

Read that slowly if you are planning to keep a stake while your associate buys in. You could be personally guaranteeing your buyer’s loan on the practice you are trying to exit.

That is not a reason to abandon the SBA path. It is a reason to plan it with a lender before you draft anything, and to confirm the current rules, since SBA guidance moves.

The owners who get surprised here are the ones who handshake the deal first and discover the financing structure second.

Phantom equity as a bridge

There is a third structure worth knowing, because it sidesteps some of the financing problem entirely. Phantom equity — units that track the practice’s value and vest over time but carry no voting rights — is a common bridge to ownership. Mandelbaum Barrett describes a typical version vesting evenly over five years, after which the associate either cashes out or converts to real equity at a pre-agreed price.

The appeal is that the associate earns their way toward ownership without needing a big loan on day one. The catch is tax.

Phantom-equity payouts and conversions are taxed as ordinary income, plus payroll tax, to the associate when settled, and the plan is non-qualified deferred compensation subject to IRS Section 409A, with only post-conversion appreciation getting capital-gains treatment. Both sides need tax counsel before they pick this route, because the structure choice changes who pays what.

The tax structure both sides forget to check

One more technical point that quietly moves money, and that owners almost never raise themselves.

How the departing owner’s interest gets bought matters for taxes. A cross-purchase — where the buying individual purchases the interest directly — gives the buyer basis equal to the purchase price, which lowers their capital gains on a later sale.

A redemption — where the practice itself buys back the interest — works differently, and in a C-corporation it does not increase the remaining owners’ stock basis.

Mandelbaum Barrett lays this out as a real fork with real consequences, mostly relevant to C-corp practices. You do not need to master it.

You need an advisor and a tax professional who flag it before the structure is locked, because reversing it after closing is expensive or impossible.

This is the recurring theme of internal sales. The friendliness of the deal makes both sides skip the technical rigor an arm’s-length sale would force, and the skipped rigor is exactly where value leaks out.

The three agreements that make it real

A handshake between two doctors who trust each other is not a deal. It is the beginning of one.

A properly structured associate sale runs on three coordinated agreements, and Mandelbaum Barrett is clear that all three have to fit together. The purchase agreement sets the price, the percentage being sold, the liabilities, and the representations and indemnities — the promises about the practice’s condition and who covers what if something was misstated.

The partnership or operating agreement governs management and decision rights, who decides what once there are two owners instead of one. The updated employment agreement covers compensation, benefits, and restrictive covenants.

Miss any one of the three and you have built a transition with a hole in it. Sell a stake with no operating agreement and you have two owners and no rulebook for disagreement.

Update no employment terms and the associate’s pay and obligations drift out of sync with their new ownership.

This is also where the wrong attorney does real damage. The veterinary M&A firm Dyer Mauro lists using a non-veterinary attorney, one who misses industry-specific compliance issues, among the most common reasons internal deals die.

A generalist drafting a vet practice transition will not know to check the things that sink vet deals specifically.

Why internal deals fall apart, and how to keep yours from

The failure pattern in internal sales is almost never what owners brace for. It is rarely a falling-out between two doctors who liked each other going in.

It is process.

Dyer Mauro catalogs the deal-killers, and every one of them is a process failure rather than a personality clash. Owners skip formal due diligence — the buyer’s confirming review of the practice’s finances and records — because the buyer “already works here” and supposedly knows everything.

The purchase agreement is left vague. The transition timeline and the question of who has authority during it are never aligned.

The associate’s financing is never pre-qualified. And the wrong attorney misses compliance issues a vet-specialist would catch.

Notice the through-line. Familiarity breeds shortcuts, and the shortcuts are what break the deal.

The associate works there, so nobody runs diligence. The two trust each other, so the contract stays loose.

Everyone assumes the financing will come together, so nobody confirms it.

The fix is to treat the internal sale with the same rigor you would give a sale to a stranger. AAHA, the American Animal Hospital Association, advises owners to begin assembling a transition team — the lawyer, accountant, banker, valuation specialist, and mentor — at least two years before a planned internal sale, and to get a veterinary-specific appraisal early.

Two years sounds like a lot until you remember the financing has to be solved, the structure chosen, and the agreements drafted before any of it closes.

An independent valuation does something subtle and important here too. Because an internal sale has no competitive bidding to discover the price, a defensible third-party appraisal keeps the number from feeling invented by either side, which protects the relationship as much as the deal.

You can think through the broader sequence in our guide to selling a veterinary practice and the due diligence work that even a friendly buyer should run.

How to decide between the inside and the outside

So you have an associate who wants in, and you have a market of outside buyers who would compete for the same practice. How should you actually choose?

Start by separating the two questions you are really asking. One is “what do I want this transition to feel like.” The other is “what is the practice worth, and to whom.” Owners collapse those into one decision and pick the associate because the human side feels obvious, before they ever measure the financial side.

Measure the financial side first, then decide. Get a real read on what a competitive external process would produce, and a defensible appraisal of the internal price, and put the two numbers next to each other.

The gap is the price of legacy. Sometimes it is small enough that the internal sale is clearly right.

Sometimes it is large enough to fund your entire retirement differently, and you deserve to see it before you sign it away.

This is the work we do at the front of every engagement, before an owner commits to any path. The methodology we use to run a competitive sale is the Elite Selling System — we hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

Even an owner who ends up selling to their associate benefits from knowing what that process would have produced, because that number is the true measure of what they are trading away.

And the two paths are not always mutually exclusive. Some owners run a competitive process to establish the real market value, then offer their associate the chance to match or come close, so the associate gets the legacy handoff and the owner gets a price anchored to the actual market rather than a guess.

You can explore the full landscape of external buyers in our guides to who to sell your veterinary practice to, the PE-backed consolidators directory, and what private equity is paying right now. The tax side of either path is worth reading early too, in our guide to the tax consequences of selling a veterinary practice.

What to do next

If you have an associate in mind, the worst thing you can do is decide before you measure. The internal sale is a fine choice.

It is a terrible default.

So before you commit, do three things. Get a veterinary-specific appraisal so the internal price is defensible and not invented.

Get a market read on what a competitive external process would actually produce, so you know the size of the trade you are making. And pre-qualify the financing — seller note, SBA, phantom equity, or a blend — before a single agreement gets drafted, because financing is the thing that actually decides whether an internal deal closes.

Then choose with your eyes open. Legacy is a legitimate reason to take less.

Taking less without knowing how much less is not legacy. It is just leaving money on the table.

Get a Free Practice Value Estimate →

We pull your numbers ourselves, build a defensible normalized EBITDA, and tell you what a competitive external process would realistically produce for your specific practice. Then, if the internal path is still what you want, you make that choice knowing exactly what it costs and exactly what your associate would need to finance.

The estimate is free and there is no obligation to engage. The Transitions Elite model is success-based, with no upfront fees and no retainer, so we are only paid when a deal closes and only out of the value our process protects and delivers.

---

Further reading

These are the related resources I would point any owner toward while weighing an internal sale against the outside market. Each goes deep on one piece of the decision.

• Valuate a veterinary practice — what your practice is actually worth, and the methods buyers use to price it.
• Sell my veterinary practice — the owner’s decision guide across every sale path, internal and external.
• Who to sell your veterinary practice to — the external buyer types, from individuals to PE-backed groups to strategics.
• How to sell a veterinary practice — the full process from advisor engagement to closing.
• Veterinary practice exit strategy — building the multi-year plan an internal sale especially requires.
• Veterinary practice brokers — what an advisor does and how engagement works.

Frequently asked questions

How does selling a veterinary practice to an associate work?

Selling to an associate is an internal sale where an employed veterinarian buys the practice, usually in phases rather than all at once. A common structure has the associate pay an initial 10 to 20 percent up front, then buy the rest over time under a promissory note, sometimes with sweat equity counting toward the percentage.

The deal runs on three coordinated agreements: a purchase agreement, a partnership or operating agreement, and an updated employment agreement. Most internal sales take longer to plan than an external sale and need an early appraisal and a financing plan.

How much does an associate pay to buy into a veterinary practice?

In a typical associate buy-in the associate pays an initial 10 to 20 percent up front and the remainder over time under a promissory note, often with sweat equity also counting toward the ownership percentage. The total price depends on the practice valuation.

Historically, doctor-to-doctor sales have priced around 80 percent of annual revenue, while a competitive external sale can clear well above that, which is why the price an associate can afford is usually lower than what an outside process produces.

Why do associates pay less than an outside buyer for a veterinary practice?

A single associate is one buyer with one checkbook competing against a market of well-capitalized outside buyers. Doctor-to-doctor sales have historically priced around 80 percent of annual revenue, while PE-backed consolidators pay well above 100 percent of annual revenue, buying at roughly 10 times EBITDA.

An associate also cannot easily get bank financing or match the scale-driven multiples that a competitive external process attracts, so the internal price is usually lower. Owners trade some price for legacy protection and a gradual, mentored transition.

Can a veterinary associate get a bank loan to buy into a practice?

It is harder than most people expect. Banks usually want a first-lien position on the entire practice, which a selling owner who keeps majority ownership during a phased buy-in cannot grant, so conventional lenders are often reluctant to finance a partial buy-in.

Seller financing frequently becomes the practical answer, with the associate repaying the owner from the profits their ownership stake generates. SBA loans can finance a full acquisition, but under the June 2025 rules a partial buy-in where the seller keeps any ownership requires every owner, including the retained seller, to personally guarantee the loan for at least two years.

What are the SBA rules for financing a veterinary practice buy-in in 2026?

Under the SBA’s SOP 50 10 8, effective June 1, 2025, a business-acquisition buyer must provide a 10 percent equity injection and contribute at least half of it, typically about 5 percent of the purchase price, in cash. A seller note can count toward the other half only if it is on full standby, meaning no principal or interest payments, for the entire loan term.

In a partial buy-in where the seller retains any ownership, all owners including the retained seller must personally guarantee the entire SBA loan for at least two years. Confirm current terms with an SBA lender before relying on them.

What is phantom equity in a veterinary practice buy-in?

Phantom equity is units that track the practice’s value and vest over time, often evenly over five years, but carry no voting rights. It is a common bridge to ownership: the associate earns and vests the units, then either cashes them out or converts them to real equity at a pre-agreed price.

Phantom-equity payouts are taxed as ordinary income to the associate when settled, and the plan is non-qualified deferred compensation subject to IRS Section 409A, so only appreciation after conversion gets capital-gains treatment. Both sides should get tax counsel before choosing this route.

What documents do you need to sell a veterinary practice to an associate?

A properly structured associate sale needs three coordinated agreements. A purchase agreement sets the price, the percentage sold, liabilities, and the representations and indemnities.

A partnership or operating agreement governs management and decision rights between the parties. An updated employment agreement covers compensation, benefits, and restrictive covenants such as non-compete and non-solicitation terms.

You also need a current veterinary-specific appraisal and a financing plan, and you should use an attorney who knows veterinary deals rather than a generalist.

Why do internal associate sales fall apart?

The most common reasons internal deals collapse are process failures, not personality clashes. Owners skip formal due diligence because the buyer already works there, the purchase agreement is left vague, the transition timeline and authority expectations are misaligned, the associate’s financing is never pre-qualified, and a non-veterinary attorney misses industry-specific compliance issues.

AAHA advises assembling a transition team, the lawyer, accountant, banker, valuation specialist, and mentor, at least two years before a planned internal sale, and getting a veterinary-specific appraisal early.

---

Sources

Veterinary buy-in structure, valuation, and transition guidance

1. Mandelbaum Barrett PC. “Associate Buy-Ins: Buying Your Employer’s Veterinary Practice.” mblawfirm.com
2. Mandelbaum Barrett PC. “Veterinary Practice Buy-In: Phantom Equity Vesting, Conversion, and Tax Implications.” mblawfirm.com
3. Dyer Mauro (DM Counsel). “Associate-to-Owner Transitions: Legal Pitfalls That Kill Deals for Veterinarians.” dmcounsel.com

Financing and SBA rules

4. Pursuit Lending. “SBA 7(a) Loan Equity Injection Requirements.” pursuitlending.com
5. SBA504Blog (Spencer Hilligoss). “Full Standby Seller Note.” sba504blog.com
6. Crestmont Capital. “Veterinary Practice Loans: Complete Financing Guide.” crestmontcapital.com